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“Surgery is not what transsexualism is ultimately about. Transsexualism is
about life.”
- Jamison Green1
Introduction
In his book, Becoming a Visible Man, Jamison Green discusses his
experience of being born a biological female.2 While Green’s parents
taught him the expected societal conduct of a little girl, such as cleaning
and housework, he felt more comfortable wearing his father’s sergeant cap
from World War II and climbing trees.3 Green describes 1991 as his year
of initiation into manhood.4 During that year, he completed sex
reassignment surgery (SRS), was reissued his corrected birth certificate,
and was “accept[ed] into a community of men.”5 The decision to undertake
the full series of surgeries for SRS is not for everyone, but Green had a
strong desire to live in the body he felt he was meant to have from the start
of his life.6 He therefore undertook the procedures at a staggering cost.7
During the first year, he spent three weeks on disability and paid $10,038.8
The subsequent two years would cost him an additional $33,025 and ten
weeks on disability.9 The total cost was $43,063 with a projected ongoing
cost of $2,700 per year for continued hormone treatment.10
Many transgender individuals are not as fortunate as Green and cannot
afford the high costs associated with hormone therapy and surgeries. Some
individuals have taken extreme measures to obtain money and hormones, as
evidenced by a 2007 ABC News story about transgender prostitutes.11 The
1. JAMISON GREEN, BECOMING A VISIBLE MAN 89 (2004).
2. See id. at 11 (explaining his struggle against the societal norms of a female child).
3. See id. (providing anecdotes of his childhood struggles but emphasizing that his
family encouraged his intellectual development and physical freedom).
4. Id. at 28.
5. See id. (elaborating upon his initiation into new communities by stating that he
took on responsibilities in the newly emerging transgender community).
6. See id. at 99 (explaining his strong desire for permanent transition-related surgery
in the summer of 1988).
7. See id. at 116–18 (outlining the costs of all of the procedures undertaken).
8. Id. at 117.
9. Id. at 117–18.
10. Id.
11. See Russell Goldman, Making Change: The Cost of Being Transgender, ABC
NEWS, May 10, 2007, http://abcnews.go.com/Health/story?id=3156598&page=1 (last visited
Nov. 1, 2011) (providing accounts of transgender prostitutes) (on file with the Washington
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report told of young girls, including twenty-two-year-old Kenyatta, who
engaged in prostitution a few times per month in order to obtain money to
purchase illegal hormones on the black market.12 Although cheaper than
hormones obtained through a physician, illegal hormones carry a higher
risk for complications.13 Without the supervision of a physician, Kenyatta
has an increased chance of developing deadly blood clots in her lungs, legs,
heart, and brain.14
Some transgender individuals take part in medical tourism and travel
to other countries.15 One example is Monika Weiss, who went to Thailand
in order to undergo procedures to become a woman.16 She spent one-third
of the amount of money she would have had to pay in the United States.17
One need spend only a few minutes searching the Internet to find the
numerous websites advertising Thailand’s cheap and easily accessible
gender reassignment procedures.18 There are consequences for traveling
abroad to receive surgery. Many surgeries are advertised on websites,19
requiring individuals to rely on their own knowledge while shopping for
surgeons. A person must, therefore, be extremely knowledgeable in order
and Lee Journal of Civil Rights and Social Justice).
12. See id. (discussing the ease of access to hormones on the black market).
13. See id. (discussing the increased health risks of taking illegal hormones without
supervision from a physician).
14. See id. (stating that progesterone has been linked to breast cancer and estrogen use
can lead to blood clots).
15. See Richard S. Ehrlich, Everything You Always Wanted to Know About
Sex . . . Changes, CNN, Feb. 24, 2010, http://www.cnngo.com/bangkok/play/everythingyouve-ever-wanted-know-about-sex-changes-379486 (last visited Nov. 1, 2011) (discussing
the price of surgery in the United States and American people traveling to Thailand for
cheaper prices) (on file with the Washington and Lee Journal of Civil Rights and Social
Justice).
16. See id. (describing the personal decision of one transgender individual to travel to
Thailand).
17. See id. (“‘I paid one-third of what I would have paid in America for the same
procedures,’ [Monika] says while recovering in Bangkok.”).
18. See Aesthetic Plastic Surgery & Sex Change Surgery Ctr., BANGKOK PLASTIC
SURGERY, http://www.bangkokplasticsurgery.com (last visited Nov. 1, 2011) (providing a
wide range of services including: breast augmentation surgery, sex change surgery, and
facial feminization surgery) (on file with the Washington and Lee Journal of Civil Rights
and Social Justice); see also DOCTOR SARAN, http://doctorsaran.com/ (last visited Nov. 1,
2011) (providing a package price list for SRS) (on file with the Washington and Lee Journal
of Civil Rights and Social Justice).
19. See, e.g., Aesthetic Plastic Surgery & Sex Change Surgery Ctr., supra note 18
(informing readers about surgeries); see also DOCTOR SARAN, supra note 18 (describing the
various surgeries offered and providing prices).
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to ensure adequate medical care abroad. Even if a patient obtains
successful surgery, the recovery period could still pose a problem. For
example, if a patient does not want to pay additional money, he or she must
return home for later portions of the recovery period, which means he or
she will not be under the supervision of the doctor who performed the
surgery.20
Monika and Kenyatta’s stories illuminate a serious issue in the United
States: If individuals need medical treatment in order to live in what they
feel is their correct biological body, why are United States citizens turning
to prostitution, the black market, and cheap procedures in foreign countries?
This Note will answer this question and advance a solution by examining
international and European standards. Part I will provide an overview of
transgender medical needs in the United States. Part II will discuss the
current barriers in the United States. Part III will examine standards created
by international organizations in order to develop medical standards for the
United States. Part IV will study how European countries implement those
international standards. Finally, Part V will apply the lessons from
international standards and European examples to the situation in the
United States in order to remedy the pressing problems affecting
transsexuals.
I. Overview of Transgender Medical Needs
Understanding the current state of healthcare for transitioning
individuals requires knowledge of the terminology regarding transgender
people as well as how the medical community approaches the situation.
The term “transgender” is now used as “an umbrella term for anyone whose
gender identity is at odds with his [or her] birth gender.”21 “Transsexual” is
a specific classification under the broader term of “transgender” and is used
to describe individuals who have an “internal gender identity that does not

20. See SRS (Penile Skin Inversion), PREECHA AESTHETIC INST., http://pai.co.th/srspenile-skin-inversion/ (last visited Nov. 1, 2011) (detailing an example of a post-operative
recovery period) (on file with the Washington and Lee Journal of Civil Rights and Social
Justice). The institute requires that the patient stay in Thailand an additional fifteen days
after surgery. Id. The recovery period, however, can last 4–8 weeks, during which
strenuous activity is discouraged. Id. If complications arise after the initial fifteen days, the
patient will often be in a different country than his or her original physician.
21. JOHN M. BURDA, GAY, LESBIAN, AND TRANSGENDER CLIENTS: A LAWYER’S GUIDE
156 (2008) (detailing a basic overview of transgender issues).
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match the sex assigned at birth.”22 Transsexuals often undergo hormone
therapy or SRS in order to correct their biological sex.23 In order for
transsexuals to pursue medical treatment in the United States, they usually
must be diagnosed with some type of gender identity disorder.24
Gender Identity Disorder (GID) is defined in the American Psychiatric
Diagnostic and Statistical Manual of Mental Disorders IV (DSM-IV),25
which lists five necessary criteria:
1. Evidence of a strong and persistent cross-gender
identification;
2. Cross-gender identification must be more than a mere desire
for the perceived cultural advantages of the other sex;
3. Evidence must exist of either a persistent discomfort with or a
sense of inappropriateness in the gender role of one’s assigned
sex;
4. The person must not have a concurrent physical intersex
condition; and
5. Evidence must exist of clinically significant distress or
impairment in social, occupational, or other important areas of
functioning. 26
Many individuals diagnosed with GID often feel intense distress called
gender dysphoria.27 If untreated, gender dysphoria can lead to severe
depression and even suicide in serious cases.28 To treat these symptoms,
transgender healthcare experts recommend a triadic therapy, which includes
a real-life experience in the desired gender role, hormone therapy, and
SRS.29
22. See id. at 156 (distinguishing transsexuals from cross-dressers because crossdressers, while dressing as the opposite sex, maintain an identity as a man or a woman and
thus conform to societal expectations).
23. See id. (stating that transsexuals often feel persistent distress, which is relieved by
hormone therapy and SRS).
24. See GREEN, supra note 1, at 93 (discussing the negative effects of classifying all
transsexuals as having a mental disorder).
25. See AM. PSYCHIATRIC ASSOC., DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL
DISORDERS 576–82 (4th ed. 2000) [hereinafter DSM-IV] (providing standard criteria for the
classification of mental disorders).
26. Id. at 581–82.
27. See BURDA, supra note 21, at 156 (“Gender dysphoria refers to the persistent
distress that transsexuals feel toward the gender assigned to them at birth.”).
28. See id. at 157 (“Untreated, the condition causes severe depression and, in some
profound cases, leads to suicide.”).
29. See id. at 156 (outlining the usual prescribed treatment for gender dysphoria).
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The real-life experience is an extended period of time during which a
patient must live in his or her preferred gender role.30 Physicians use the
real-life experience, often for a twelve-month minimum, to test whether
there is further consolidation of gender identity in the patient.31 Coupled
with the real-life experience, psychotherapy helps to further the goal of a
stable lifestyle.32 Therapy helps to illuminate the patient’s history as well
as his or her current expectations.33 The goal of these two procedures is to
ensure that the patient actually wants to undergo gender reassignment and
that he or she is psychologically prepared for the start of the process.34
Once a patient has begun the real-life experience and completed three
months of psychotherapy, a physician may prescribe hormone treatment.35
The positive effects of hormones often take years to develop; hormones are
administered over a period of time before, during, and after SRS.36
Numerous medical risks are associated with hormone therapy, including
adverse effects on liver function and an increased risk of
hyperprolactemia.37 As a result of these risks, there is a strong need for
30. See RACHEL ANN HEATH, THE PRAEGER HANDBOOK OF TRANSSEXUALITY:
CHANGING GENDER TO MATCH MINDSET 80 (Judy Kuriansky ed., 2006) (stating that the reallife experience is often for a minimum of twelve months but can be extended up to two
years).
31. See WORLD PROF. ASSOC. OF TRANSGENDER HEALTH [WPATH], STANDARDS OF
CARE
FOR
GENDER
IDENTITY
DISORDERS
14
(2001),
available
at
http://www.wpath.org/documents2/socv6.pdf (outlining the three readiness criteria for
hormone therapy).
32. See id. at 12 (explaining that the goal of psychotherapy is not to cure GID but to
help provide a stable lifestyle with realistic chances for relationships, work, and gender
identity expression).
33. See id. (“[Therapy] enable[s] the patient’s history [to] be appreciated, current
dilemmas to be understood, and unrealistic ideas and maladaptive behaviors to be
identified.”).
34. See id. (defining the process of psychotherapy). The author notes:
The therapist should make clear that it is the patient’s right to choose among
many options. The patient can experiment over time with alternative
approaches. Ideally, psychotherapy is a collaborative effort. The therapist must
be certain that the patient understands the concepts of eligibility and readiness,
because the therapist and patient must cooperate in defining the patient’s
problems, and in assessing progress in dealing with them.
Id.
35. See HEATH, supra note 30, at 113 (stating that transsexed men begin taking
testosterone and transsexed women begin taking estrogen once a diagnosis of transsexualism
is made).
36. See id. (stating that the positive effects of hormone therapy takes two or more
years to develop).
37. See id. at 116–17 (concluding that hormone therapy is reasonably safe for both
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close observation by a physician or endocrinologist throughout the entire
period of hormone therapy.38
The final part of the suggested triadic therapy is the surgery itself,
which many patients do not choose.39 SRS may include a number of
different procedures. Genital reconstruction surgery is complex for both
sexes.40 For transsexual women, one procedure is called a vaginoplasty,
which involves the creation of a vagina using both penile skin and a
urethral flap.41 For transsexual men, phalloplasty, or the creation of a penis,
is accomplished through a variety of intricate methods.42 Men can
additionally receive a hysterectomy, oophorectomy, vaginectomy, and
mastectomy.43
After the primary surgical procedures, transsexual
transsexed women and men, but that the risks associated with it require observation by an
endocrinologist). Hyperprolactemia is a disorder of the pituitary gland that results in an
excess secretion of prolactin. Id. at 116.
38. See id. at 116 (stating that an endocrinologist should be aware of the possible
complications associated with hormone therapy and make the risks clear to the patient).
39. See id. at 82 (explaining Harry Benjamin’s categories of transvestites and
transsexuals). A nonsurgical transsexual frequently dresses as the opposite biological sex
and requests hormone therapy to maintain a satisfactory quality of life. Id. What Benjamin
terms as a “true transsexual” requests gender reassignment surgery and hormone therapy.
Id.
40. See id. at 124 (“The surgical procedures required to transform the male genitals
into their female equivalent are complex.”). Even though complex, genital reconstruction
surgery “for transsexed women provides a satisfying outcome both cosmetically and
functionally in most cases.” Id. at 134. The procedures for transsexed men, however,
“involve an unreasonable degree of cost, risk, and compromise.” Id. Much of the
complication results from the goal of phalloplasty, which is to “create a penis that has erotic
sensation and is capable of both sexual intercourse and urination while standing.” Id. Since
the procedures for transsexed men are so complex and uncertain, many men are content with
hormone therapy and cosmetic surgeries. Id.
41. See id. at 124–29 (describing the surgical procedure of a vaginoplasty in detail).
42. See id. at 134–37 (detailing the different options for the phalloplasty surgery).
One method for phalloplasty “uses a bony skin graft from the underside of the forearm.” Id.
at 134. Another method produces a tube from “innervated skin from the lower abdomen.”
Id. at 135. The urethra is then constructed using a fold of skin from the labia majora and
placed within the penis to allow urination while standing. Id. As an alternative to
phalloplasty, men can undergo metoidioplasty, which creates a penis by using the enlarged
clitoris that results from prolonged testosterone use. Id. at 136.
43. See id. (discussing a new surgical procedure that uses a one-stage procedure). The
study notes:
Mastectomy and chest contouring are performed at the same time as
oophorectomy (removal of the ovaries) and hysterectomy. The procedure
concludes with phalloplasty, the penis being formed from a skin flap obtained
from the anterior abdomen wall.
Id.
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individuals can also receive treatment in the form of speech therapy, voice
box surgery, and facial feminization therapy.44
The costs and extent of psychological evaluations, hormone therapy,
and surgical procedures make them difficult to obtain for a large portion of
the transgender community.45 A 2001 survey found that the average cost
for male to female SRS was approximately $10,400.46 Prices of wellknown surgeons ranged from $4,500 to $26,000 for male to female
surgeries.47 Female to male surgeries ranged from $4,000 up to $60,000
and averaged $18,000 in 2001.48 In addition to surgeries, the study
estimated mental therapy sessions at a rate of $125 per hour and assumed
the average person to need at least four sessions annually.49 Patients who
have already transitioned and are functioning well in their new gender roles
will need approximately two or three sessions per year, whereas a newly
transitioned or transitioning individual may need up to twenty sessions per
year.50
Hormones are also costly.51 Male to female patients could spend well
over $1,000 for the first year of hormone treatment and over $2,000 for the
second year.52 After transitioning, the price for hormones remains fairly
44. See id. at 141–54 (discussing the various ancillary procedures available to
transsexual patients).
45. See BURDA, supra note 21, at 157 (stating that SRS is expensive and often not
covered by many Medicaid statutes and private insurance companies, resulting in many
transsexuals not being able to afford the procedures).
46. See MARY ANN HORTON, THE COST OF TRANSGENDER HEALTH BENEFITS, OUT &
EQUAL WORKPLACE SUMMIT 1 (2008), http://www.tgender.net/taw/thb/THBCostOE2008.pdf (last visited Oct. 18, 2011) (estimating the cost of Transgender Health Benefits
for United States residents) (on file with the Washington and Lee Journal of Civil Rights and
Social Justice). The study notes:
The author sent a survey in 2002 to all surgeons and clinics who were members
of HBIGDA (Harry Benjamin International Gender Dysphoria Association),
asking for data of primary surgeries performed in 2001: number, cost, and
fraction who were US residents, separately for MTF (male to female) and FTM
(female to male) patients.
Id. at 2.
47. Id.
48. Id. at 1–2.
49. See id. (estimating that a total first year cost of mental health therapy would total
$750).
50. Id. at 5–6.
51. See id. at 6–7 (discussing the costs associated with hormone therapy).
52. See id. at 6 (detailing the typical path of hormone treatment and the total cost of
medicines per year). The study notes:
In the first year, the Premarin dose gradually increases from .625 mg/day to
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consistent at approximately $400 per year.53 Female to male patients have a
simpler regimen that costs approximately $229 per year.54 Transitioning
individuals face additional charges for doctor’s visits and yearly blood tests
to determine hormone levels.55
II. Barriers to Transition-Related Medical Care in the United States
Transsexuals seeking medical treatment in the United States face
difficulties inherent in the transgender experience as well as difficulties
resulting from the lack of uniform medical standards among the states.56
For example, an October 2010 survey evaluating transgender discrimination
in health care found that study participants were less likely than the general
population to have health insurance and more likely to be covered by state
programs such as Medicaid.57 Medicaid statutes among the states differ as
to whether or to what extent SRS and related services qualify as “medically
necessary.”58
Private insurance companies also pose problems for
transgender individuals because most of them either expressly exclude
3.75 mg/day, the dosage of Spironolactone remains steady at 100 mg/day, for a
total cost of $1,088. In the second year, .5 mg/day of Premarin, 100 mg/day of
Spironolactone, and 200 mg/day of Prometrium is assumed, costing a total of
$2,376.
Id.
53. See id. (“In years 3 and on, a maintenance dose of 1.25 mg of Premarin, costing
$382 per year is assumed.”).
54. See id. (assuming that it is a constant dosage of 1.0 cc of injectable DepoTestosterone every two weeks that does not change over the lifetime of the patient).
55. See id. at 7–8 (stating that costs for doctor’s visits will typically be $510 in the
first year, $385 the second year, and $225 in subsequent years).
56. See HEATH, supra note 30, at 169 (stating that transsexuals often “experience
prejudice and . . . negative responses from caregivers”).
57. See JAIME M. GRANT ET AL., THE NAT’L CTR. FOR TRANSGENDER EQUAL. & THE
NAT’L GAY AND LESBIAN TASK FORCE, NAT’L TRANSGENDER DISCRIMINATION SURVEY
REPORT ON HEALTH AND HEALTH CARE 8 (2010), available at http://transequality.
org/PDFs/NTDSReportonHealth_final.pdf [hereinafter NCTE] (stating that 19% of the
survey sample lacked any health insurance compared to 15% of the general population).
58. See Know Your Rights—Transgender People and the Law, AM. CIVIL LIBERTIES
UNION (ACLU), Nov. 19, 2009, http://www.aclu.org/hiv-aids_lgbt-rights/know-your-rightstransgender-people-and-law (last visited Oct. 18, 2011) (stating that it is difficult to get
Medicaid coverage of transition-related care) (on file with the Washington and Lee Journal
of Civil Rights and Social Justice). The article further states that “[n]o state explicitly
permits it, and many states explicitly deny it. In those that do not explicitly permit or deny
it, coverage may still be denied under the rationale that transition-related treatment is
‘experimental’ or ‘cosmetic.’” Id.
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transition-related services or are unclear about the services covered.59 A
lack of federal legislation providing for uniform medical standards among
the states contributes to the difficulty of funding coverage for transitionrelated care.60
A. State Medicaid Statutes
Medicaid statutes vary from state to state.61 The federal Medicaid
statute does not exclude reimbursement of treatments related to SRS, but
states can choose whether to reimburse certain medical procedures under
their programs.62 There are some favorable regulations and case law
maintaining that states cannot categorically deny compensation for SRS
under Medicaid programs, but there is also case law upholding states’
denial of reimbursement for treatment related to SRS.63
Although states may choose which medical procedures to reimburse
under Medicaid, regulations constrain that choice.64 For example, states
may not deny services to an otherwise eligible individual solely because of
diagnosis, type of illness, or condition.65 The United States Court of
Appeals for the Eighth Circuit has held that states cannot absolutely
exclude the only known available medical treatment for a gender identity
disorder because that would be considered an arbitrary denial of benefits
based solely on the diagnosis, type of illness, or condition.66 In Pinneke v.
59. See id. (stating that coverage of transition-related surgery or treatment depends on
the specific contract with the health insurance companies).
60. See id. (stating that the two government programs addressing transition-related
care, Medicare and the Civilian Health and Medical Program of the Uniformed Services,
exclude transition-related services).
61. See BURDA, supra note 21, at 174 (providing some examples of states that
excluded SRS).
62. See id. (stating that there is some favorable case law, but that it is difficult to
obtain reimbursement through Medicaid).
63. See discussion infra at notes 64–83 (discussing case law allowing states to deny
reimbursement for transition-related services).
64. See 42 U.S.C. § 1396(a)(A)(10) (2010) (providing a list of care and services that
must be provided in order for medical assistance).
65. See 42 C.F.R. § 440.230(c) (2011) (“The Medicaid agency may not arbitrarily
deny or reduce the amount, duration, or scope of a required service under §§ 440.210 and
440.220 to an otherwise eligible recipient solely because of the diagnosis, type of illness, or
condition.”).
66. See Pinneke v. Preisser, 623 F.2d 546, 549 (8th Cir. 1980) (stating that there
cannot be an irrebuttable presumption that SRS is never medically necessary). AppelleePlaintiff Pinneke underwent extensive testing and doctors concluded that she had a
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Preisser, the court stated that the Iowa Department of Social Services could
not create an irrebuttable presumption that SRS can never be medically
necessary and that it must take into account the applicant’s diagnosed
condition, the prescribed treatment, and the knowledge of the medical
community.67 The Supreme Court of Minnesota, in Doe v. State,68 required
an unbiased medical evaluation of whether SRS is medically necessary as
determined on a case-by-case basis.69
Although cases such as Pinneke and Doe illustrate that there have been
some successes in obtaining funding for SRS, there are also numerous cases
reaching the opposite result under a variety of rationales. In Casillas v.
Daines,70 Terri Casillas claimed that the New York Commissioner of
Health deprived her of rights protected by the Constitution and federal law
when he denied her Medicaid coverage for surgeries and services to treat
her GID.71 The New York State Department of Health adopted a regulation
that prohibits state Medicaid reimbursement for services related to gender
reassignment.72 Casillas, with the support of her current psychologist and
transsexual personality. Id. at 547. Eligible under the Medicaid program, she applied for
funding of her SRS, but was denied. Id. The court found that sex conversion surgery is the
only medical treatment available to relieve the problems of a true transsexual. Id. at 548.
Furthermore, the court concluded that the state plan was an arbitrary denial of benefits based
solely on the “diagnosis, type of illness, or condition” since it absolutely excluded the only
known treatment. Id. at 549.
67. See id. at 549–50 (stating that the decision of whether a certain treatment is
“medically necessary” rests with the individual’s physician and not with government
officials).
68. See Doe v. State, 257 N.W.2d 816, 821 (Minn. 1977) (finding that the Minnesota
Welfare Department’s denial of medical assistance benefits to an adult male transsexual was
arbitrary and unreasonable). Jane Doe was selected to undergo sex conversion surgery at
one of the University of Minnesota Hospitals. Id. at 817. The federal funding for the
program ended before Doe could undertake surgery. Id.
69. See id. at 820 (“The determination of medical necessity through a thorough
medical evaluation of the individual applicant will ensure that those individuals genuinely
requiring sex conversion surgery will be able to obtain it but will deny benefits to persons
not demonstrating such medical necessity.”).
70. See Casillas v. Daines, 580 F. Supp. 2d 235, 247 (S.D.N.Y. 2008) (granting the
motion of the defendant for judgment on the pleadings). Terri Casillas claimed that the New
York Commission of Health violated her equal protection rights by denying her
reimbursement under Medicaid for services related to GID. Id. at 237. The state agency
cited “serious complications” from the surgeries and the administration of estrogen. Id. at
247. The court found that the state agency’s rationale provided a more than sufficient
rational basis related to the government interest of protecting the health of its citizens and
the conservation of limited medical resources. Id.
71. See id. at 237 (arguing that SRS, hormone therapy, and real-life experience
together are an effective treatment for transsexualism or profound GID).
72. See id. at 237 (citing 18 N.Y.C.R.R. § 505.2(1) (2011)).
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her prior treating psychiatrist, argued that the treatments were medically
necessary.73 Casillas argued that she had been denied equal protection on
the basis of her diagnosis, but the court disagreed.74 The state agency cited
serious complications from the surgery and from the administration of
estrogen.75 The court ruled against Casillas and found that the agency’s
explanation survived rational basis review because it was protecting the
health of state citizens and conserving limited medical resources.76
Other courts have upheld the categorical denial of reimbursement for
transition-related medical care on the grounds that SRS is “experimental”
and that there is disagreement with regards to the efficacy of such
procedures.77 The court in Rush v. Parham78 stated that the federal
Medicaid statute gives states broad discretion for adopting standards and
only requires that those standards be reasonable and consistent with the
objectives of the Act.79 In Rush, the United States Court of Appeals for the
Fifth Circuit found that Georgia could reasonably exclude reimbursement
of experimental treatments and remanded for the district court to determine
if the specific procedures could be classified as such.80 In Smith v.
Rasmussen,81 the United States Court of Appeals for the Eighth Circuit
upheld Iowa’s prohibition on funding of SRS.82 Instead of concluding that
73. See id. at 238 (“In January 2007, plaintiff was examined by a medical doctor who
is Professor and Chairman of Plastic and Reconstructive Surgery at the Philadelphia College
of Osteopathic Medicine who has opined that hormones, orchiectomy and vaginoplasty are
medically necessary to treat plaintiffs with GID.”).
74. See id. at 246–47 (stating that the state agency satisfied a rational basis related to a
legitimate government interest).
75. See id. at 247 (citing the agency’s rationale for denying reimbursement of gender
reassignment surgeries and associated treatments).
76. See id. (“This provided a more than sufficient rational basis which was related to
legitimate government interests—the health of its citizens and the conservation of limited
medical resources.”).
77. See Rush v. Parham, 625 F.2d 1150, 1156 (5th Cir. 1980) (holding that Georgia
could exclude SRS because of its status as an experimental treatment).
78. See id. (finding that Georgia’s definition of “medically necessary” could
reasonably exclude experimental treatment).
79. See id. at 1155 (giving broad discretion to states when deciding which treatments
to cover under Medicaid programs).
80. See id. at 1156–57 (remanding the case to determine if the specific procedures
could be classified as experimental).
81. See Smith v. Rasmussen, 249 F.3d 755, 762 (8th Cir. 2010) (finding that the
rulemaking process resulted in a reasonable regulation that overcame the presumption in
favor of the treating psychiatrist).
82. See id. at 760–61 (describing the rulemaking process that caused the exclusion of
SRS).
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the procedures were categorically experimental, the court cited the
Department of Health’s research that demonstrated differing opinions
regarding the efficacy of SRS.83
As evidenced by the decisions in Rush and Smith, there is
disagreement in the United States medical community over the efficacy of
both SRS and the various other components of transition-related care. A
further complication caused by the Medicaid program is that states may
place reasonable limits on a physician’s discretion as to which medical
procedures qualify as medically necessary.84 Even if a doctor does decide
that transition-related care is medically necessary for a patient, a state may
still deny coverage as long as it has a legitimate interest, such as conserving
resources.85
B. Private Insurance Companies
The difficulties associated with coverage under state Medicaid
programs leave many transsexuals relying on private insurance in order to
fund transition-related medical care.86 The first obstacle is affording private
insurance. Transgender people often find economic and educational
opportunities inaccessible due to persistent discrimination throughout their
lifetimes.87 Many transgender individuals drop out of school before
finishing high school due to a lack of uniform anti-discrimination policies.88
A large portion of the transgender community therefore faces financial
hardships that make affording private insurance nearly impossible.89
83. See id. at 761 (noting that the efficacy of surgery has been questioned).
84. See Rush v. Parham, 625 F.2d 1150, 1156 (5th Cir. 1980) (detailing the ability of
states to establish standards for individual physicians in determining what services are
appropriate).
85. See Smith, 249 F.3d at 761 (noting the relevance of economic concerns and the
state’s interests in a state’s decision whether to cover SRS).
86. See NCTE, supra note 57, at 8 (providing the percentages of respondents’ source
of insurance). While 3% of respondents received insurance through Medicaid, 7% of
respondents purchased insurance. Id. In addition, 51% of respondents had insurance
through either their own employer or through someone else’s employer. Id.
87. See Dean Spade, Compliance is Gendered: Struggling for Gender SelfDetermination in a Hostile Economy, in TRANSGENDER RIGHTS 217, 218–19 (Paisley Currah,
Richard M. Juang, & Shannon Price Minter eds., 2006) (stating that much of the economic
and educational discrimination against transgender individuals remains legal).
88. See id. at 219 (stating that harassment is widespread in schools). Many
transgender people do not pursue higher education out of fear of applying to schools and
needing to fill out applications, which will reveal their previous sex and name. Id.
89. See id. (“Furthermore, trans people face severe discrimination in the job market

364

18 WASH. & LEE J.C.R. & SOC. JUST. 351 (2012)

Even if an individual can acquire private health care, there are still the
additional obstacles of discrimination and exclusion of procedures. There
has been some progress in protecting transgender individuals from
discrimination in general.90 One example is the Patient Protection and
Affordable Care Act which bans insurance companies from dropping or
denying coverage because of a pre-existing condition.91 While the bill
prevents discrimination because someone is transgender or diagnosed with
GID, it does not prevent insurance companies from excluding certain types
of medical procedures.92 Because contract law governs private insurance, it
is often up to the individual to ensure that the plan he or she purchases
includes coverage for transition-related care.93 Most insurance carriers
either exclude many forms of transition-related care or are unclear about
whether those services are covered.94
Insurance companies commonly state that SRS is a cosmetic procedure
and therefore not coverable under insurance plans.95 In Davidson v. Aetna
Life & Casualty Co.,96 Victoria Davidson had an insurance policy through
his employer stating that cosmetic surgeries would be covered only if the
“surgery is necessary for the repair of non-occupational injury.”97 Aetna
attempted to argue that sex-reassignment surgery is cosmetic and not
necessary to repair an injury.98 The court ruled for Davidson, finding that
and are routinely fired for transitioning on the job or when their gender identities or
expressions come to their supervisor’s attention.”).
90. See Patient Protection and Affordable Care Act, Pub. L. No. 111-148, § 1205, 124
Stat. 119 (2010) (preventing discrimination based on one’s transgender identity); see also
Davidson v. Aetna Life & Cas. Ins. Co., 420 N.Y.S.2d 450, 453 (N.Y. 1979) (finding that
SRS is not merely cosmetic surgery).
91. See Patient Protection and Affordable Care Act § 1205 (banning denial of
coverage due to a previous condition); see also THE HENRY J. KAISER FAM. FOUND.,
SUMMARY OF NEW HEALTH REFORM LAW 1 (April 15, 2011), available at
http://www.kff.org/healthreform/upload/8061.pdf (stating that the new bill extends Medicaid
coverage to all individuals under the age of sixty-five).
92. See Patient Protection and Affordable Care Act §§ 1557, 2704 (prohibiting
exclusion of preexisting conditions and preventing discrimination in coverage).
93. See ACLU, supra note 58 (stating that coverage depends upon the individual
contract with the individual insurance company).
94. See id. (“Today, most insurance contracts either expressly exclude many forms of
transition-related services or are unclear about whether such services are covered.”).
95. See Davidson, 420 N.Y.S.2d at 451 (stating that the defendant argued that the
transsexual surgery in question was cosmetic).
96. See id. at 453 (finding that the SRS in question was necessary for the treatment of
gender dysphoria).
97. Id. at 451.
98. See id. at 452–53 (stating that Aetna’s Medical Director maintained that there is
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the procedure is performed in order to correct a psychological defect, not
solely to improve muscle tone or physical appearance.99 While Davidson
was a victory for transgender individuals, the case also illuminates the fact
that the outcome is dependent upon whether courts view transition-related
care as medically necessary.100
C. Consequences of the Difficulty to Access Transition-Related Care
Because of the difficulties associated with financing SRS and related
treatment, many transsexuals turn to negative coping mechanisms.101 In a
2010 survey conducted by the National Center for Transgender Equality
and the National Gay and Lesbian Task Force, surveyors asked participants
about drug and alcohol use as a coping strategy for dealing with
mistreatment and discrimination.102 Among respondents, 26% currently use
or have used alcohol and drugs to cope with discrimination.103 When asked
about suicide, 41% of respondents said they had attempted suicide.104
Numerous individuals avoid doctors and insurance companies in the
United States by seeking alternative sources for surgery and funding for
surgery.105 One alternative is traveling to Thailand, which offers cheap and
easy access to transition-related treatments.106 Hormones are particularly
easy to find and individuals can often obtain them without a doctor’s
nothing physically wrong with a transsexual’s body). He went further to say that the surgery
was attempting to change the body to fit the transsexual’s mind. Id. at 453.
99. See id. at 453 (stating that the court did not want to interfere with the professional
judgment of medical experts). The court characterized cosmetic surgery as “optional or
elective.” Id. The medical diagnosis for the plaintiff indicated that the surgery was
imperative in order for the plaintiff to live a normal life. Id.
100. See id. at 451–53 (analyzing the current understanding of transsexualism as a
medical diagnosis). Ultimately, the decision to require coverage under an insurance plan
depends on each individual’s case.
101. See NCTE, supra note 57, at 14 (describing the damaging coping mechanisms to
which transsexuals turn).
102. See id. (stating that the survey did not ask about general use of alcohol and drugs,
only about use as a coping strategy).
103. Id.
104. See id. (estimating that only 1.6% of currently living Americans have attempted
suicide).
105. See discussion supra Introduction (describing the personal stories of transsexuals
who travelled to other countries for treatment).
106. See discussion supra Introduction (discussing the experience of Monika Weiss
who spent one-third of what she would have in the United States).
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prescription.107 SRS is easier to obtain due to the lack of medical standards
associated with the Western transgender experience.108 Primarily, the
requirement that a person live in his or her desired gender for a period of
time, as well as the three-month psychological counseling, are not
mandatory in Thailand.109 After surgery in another country, the patient
faces the further problem of arranging follow-up care.110 Traveling back to
the United States requires a patient to undergo the healing process, as well
as continued hormone therapy, under the supervision of a doctor who did
not perform the surgery and who does not have an extensive knowledge of
the patient’s medical history.111
Ultimately, SRS has become a
commercially driven enterprise.112
Patients seek out the cheapest
procedures without considering the risks associated with those
procedures.113
While some transsexuals travel to other countries to obtain SRS, others
turn to prostitution in order to afford hormones on the black market.114 One
can obtain hormones from Mexico at a reduced price and without a doctor’s
prescription.115 Because of the complexity of administering hormones over
a transsexual’s lifetime, endocrinologists and physicians are crucial to
ensuring that a person is not subject to adverse side effects.116 These side
effects include nausea, vomiting, headaches, mood swings, blood clots,
107. See Sam Winter, Country Report: Thailand, TRANSGENDERASIA (Feb. 5, 2002),
http://web.hku.hk/~sjwinter/TransgenderASIA/country_report_thailand.htm (last visited
Nov. 3, 2011) (stating that local chain drug stores can carry as many as twenty-three
hormonal preparations, which are available without a prescription) (on file with the
Washington and Lee Journal of Civil Rights and Social Justice).
108. See id. (stating that the WPATH Standards of Care are not followed in Thailand).
109. See id. (stating that the requirements for the real life test and for psychiatric
counseling are not needed in Thailand).
110. See HEATH, supra note 30, at 114 (emphasizing the need for transitioning patients
to remain under the care of a physician).
111. See discussion supra Introduction (reporting the story of Monika Weiss who
traveled to Thailand to undergo SRS).
112. See HORTON, supra note 46, at 2 (finding that some SRS treatments cost as much
at $60,000).
113. See discussion supra Introduction (recounting stories of people who sought
treatment in other countries due to cost).
114. See Goldman, supra note 11 (discussing how some New York City transsexuals
turn to prostitution to afford treatments).
115. See id. (stating that hormones on the black market are usually hormones prescribed
for menopause).
116. See HEATH, supra note 30, at 114 (stating that the patient should be in constant
contact with a medical advisor throughout hormone therapy).
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liver damage, and heart and lung complications, as well as problems with
blood circulation and an increased chance of breast cancer.117
There are significant consequences to a lack of uniform medical
standards. Transgender individuals already face significant discrimination
and inequalities in most aspects of life, including housing, employment, and
education.118 The high costs associated with the full transition experience
make full treatment unobtainable for a large portion of the transgender
community who seek to transition.119 Without an easy way to obtain
medical care, many transsexuals face serious risks.
III. The International Organizational Approach to Transgender Healthcare
Although there is division within the United States over how to
approach transsexual medical care, the international medical community
has begun to formulate standards of care.120 International communities,
particularly in Europe, have seen great progress in providing protections for
sexual orientation and gender identity, but the community has remained
“fragmented and inconsistent.”121
A. Addressing Discrimination in Healthcare: The Yogyakarta Principles
In order to remedy these inconsistencies, human rights experts met in
Yogyakarta, Indonesia in November 2006 and adopted the Yogyakarta
Principles on the Application of International Human Rights Law in
Relation to Sexual Orientation and Gender Identity.122 The Yogyakarta
117. See id. (detailing the risks associated with prolonged hormone therapy).
118. See CHRISTOPHER A. SHELLEY, TRANSPEOPLE: REPUDIATION, TRAUMA, HEALING
82–91 (2008) (discussing the difficulties transsexuals face in employment and education).
119. See supra Part I (discussing the costs of transition-related services).
120. See supra Part II.B (discussing differing court decisions and jurisdictions in the
United States).
121. See THE YOGYAKARTA PRINCIPLES ON THE APPLICATION OF INTERNATIONAL
HUMAN RIGHTS LAW IN RELATION TO SEXUAL ORIENTATION AND GENDER IDENTITY 6 (Mar.
2007), http://www.yogyakartaprinciples.org/principles_en.pdf (last visited Nov. 3, 2011)
[hereinafter YOGYAKARTA] (discussing the current state of the international community as it
has approached issues of gender identity and sexual orientation) (on file with the
Washington and Lee University Journal of Civil Rights and Social Justice).
122. See id. at 6–7 (introducing the reasons for creating the principles, stating that “[a]ll
human beings are born free and equal in dignity and rights” and “[a]ll human rights are
universal, interdependent, indivisible and interrelated”).
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Principles are a broad set of standards that recognize that all state actors
should promote and protect human rights.123
Principle Seventeen of the Yogyakarta Principles is particularly
important in the healthcare context and addresses the right to the highest
attainable standard of health.124 The signatories conclude that states should
take all necessary measures to ensure enjoyment of the highest standard of
health regardless of sexual orientation or gender identity.125 Subsection C
emphasizes the need of states to “[e]nsure that healthcare facilities, goods,
and services are designed to improve the health status of, and respond to the
needs of, all persons . . . .”126 The recognition of the need to provide
adequate healthcare to all is important to the current discussion because
much of the discord among United States courts and insurance carriers
involves disagreement about which procedures are medically necessary for
gender variant individuals.127 Subsection G of the Yogyakarta Principles
provides some possible clarification of this question by urging states to
facilitate access to body modification related to gender reassignment.128
The Yogyakarta Principles reflect international recognition of the need
for standards in the area of transgender medical care. The United States, as
a participant in a larger international community, can therefore look to
international examples as a way of developing domestic medical standards.
It is true that inconsistent standards exist both in the United States medical
communities and among some international medical communities, but
examination of recently accepted international standards, in Europe and in
certain areas of the United States, begin to reveal growing continuity.129 In
order to understand the complex and emerging standards of care for
transgender health, a good starting point is to examine relevant international
organizations and the standards developed by them. Countries and medical

123. See id. at 7 (explaining the purpose and scope of the principles).
124. See id. at 22 (“Everyone has the right to the highest attainable standard of physical
and mental health, without discrimination on the basis of sexual orientation or gender
identity.”). “Sexual and reproductive health is a fundamental aspect of this right.” Id.
125. See id. (stating that states should “[t]ake all necessary legislative, administrative
and other measures” to ensure access to healthcare without discrimination).
126. Id.
127. See supra Part II.B (discussing United States court decisions and varying
approaches insurance carriers take).
128. See supra note 121, at 22 (stating that states should facilitate access to competent,
non-discriminatory treatment, care, and support).
129. See discussion infra Part IV (discussing the European approach to funding
transition-related care).
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care providers can then implement the standards or use them as flexible
guides for their respective medical systems.130
B. Addressing Specific Needs of Transgender Individuals: The World
Professional Association for Transgender Health
The World Professional Association for Transgender Health
(WPATH) is the most widely known professional organization devoted to
the understanding and treatment of GID.131 WPATH strives to bring
together international professionals in order to develop the best practices
and policies to promote the health, research, education, and overall equality
of transgender, transsexual, and gender-variant people.132 The organization
has developed a set of standards and has released a number of statements
and clarifications that countries around the world have adopted or
implemented.133
WPATH published the first version of its Standards of Care in 1979,
with the most recent revision in February 2001.134 The Standards of Care
130. See Dr. Anne Lawrence, Practice Information, http://www.annelawrence.
com/practice/index.html (last visited Oct. 4, 2011) (providing the practice information for
Anne A. Lawrence, located in Seattle, Washington, among which is a provision stating that
she regards the WPATH standards as flexible guidelines) (on file with the Washington and
Lee Journal of Civil Rights and Social Justice).
131. See WORLD PROF. ASS’N FOR TRANSGENDER HEALTH, http://www.wpath.org (last
visited Oct. 18, 2011) (describing the organization) (on file with the Washington and Lee
Journal of Civil Rights and Social Justice).
132. See Mission Statement, WORLD PROF. ASS’N FOR TRANSGENDER HEALTH,
http://www.wpath.org/about_mission.cfm (last visited Oct. 18, 2011) (outlining the mission
statement of the organization) (on file with the Washington and Lee Journal of Civil Rights
and Social Justice).
133. See WORLD PROF. ASS’N FOR TRANSGENDER HEALTH, THE HARRY BENJAMIN
INTERNATIONAL GENDER DYSPHORIA ASSOCIATION’S STANDARDS OF CARE FOR GENDER
IDENTITY DISORDERS (6th ed. 2001) [hereinafter STANDARDS OF CARE], available at
http://www.wpath.org/documents2/socv6.pdf (providing flexible standards of care for
Gender Identity Disorders); see also Clarification on Medical Necessity of Treatment, Sex
Reassignment, and Insurance Coverage in the U.S.A., WORLD PROF. ASS’N FOR
TRANSGENDER
HEALTH
(2008)
[hereinafter
WPATH
CLARIFICATION],
http://www.wpath.org/documents/Med%20Nec%20on%202008%20Letterhead.pdf
(last
visited Nov. 3, 2011) (clarifying that sexual reassignment surgery and hormone therapy for
transgender individuals should be classified as a medical necessity and covered under U.S.
insurance plans) (on file with the Washington and Lee Journal of Civil Rights and Social
Justice).
134. See STANDARDS OF CARE, supra note 133, at 1 (discussing the history of the
standards of care, which originated as the Harry Benjamin International Gender Dysphoria
Association’s Standards of Care).
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are meant to serve as flexible instructions for the treatment of individuals
with GID.135
By providing a set of minimum standards for
psychotherapeutic, endocrine, and surgical therapy, WPATH hopes to
further “lasting personal comfort with the gendered self in order to
maximize overall psychological well-being and self-fulfillment.”136
The Standards of Care begin by describing the history of gender
identity disorders and by providing criteria for diagnoses.137 Individuals are
classified as suffering from a gender identity disorder when they meet
specified conditions in one of two official nomenclatures: the International
Classification of Diseases-10 (ICD-10) or the Diagnostic and Statistical
Manual of Mental Disorders (DSM-IV).138 Under the DSM-IV committee
criteria, a person with a “strong and persistent cross-gender identification
and a persistent discomfort with their sex or a sense of inappropriateness in
the gender role of that sex” is diagnosed with gender identity disorder.139
Under the ICD-10, other criteria provide more specific diagnoses.140 In
order for an individual to be classified as “transsexual,” the individual must
have a desire to live and be accepted as a member of the opposite sex; the
transsexual identity must have been present for at least two years; and the
disorder must not be the symptom of another mental disorder or
chromosomal abnormality.141
The ICD-10 criteria also state that
transsexuals usually undertake surgery and hormone therapy as
treatment.142
135. See id. at 1–2 (stating that the eligibility requirements are supposed to be
minimums, which the individual professionals may modify).
136. See id. at 1 (explaining the overarching treatment goal of psychotherapeutic,
endocrine, and surgical therapies).
137. See id. at 1–2 (outlining how professionals diagnose gender identity disorders).
138. See id. at 2 (describing the clinical threshold in gender identity cases). The author
notes:
A clinical threshold is passed when concerns, uncertainties, and questions about
gender identity persist during a person’s development, become so intense as to
seem to be the most important aspect of a person’s life, or prevent the
establishment of a relatively unconflicted gender identity.
Id.
139. Id. note 133, at 4 (noting that the term “transgender” has been used in various
ways and is not a formal diagnosis, but many professionals use it because it is often easier to
use than the formal diagnosis).
140. See id. at 4–6 (detailing the criteria for transsexualism, dual-role transsexualism,
gender identity disorder of childhood, and other gender disorders).
141. See id. at 4–5 (listing the three criteria for transsexualism specifically).
142. See id. at 5 (“The desire to live and be accepted as a member of the opposite sex,
usually accompanied by the wish to make his or her body as congruent as possible with the
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Recognizing the difficulties transgender individuals face when
pursuing surgery in the United States, WPATH released a “Clarification on
Medical Necessity of Treatment, Sex Reassignment, and Insurance
Coverage in the U.S.A.”143 This document calls for changes in the way the
United States views and handles SRS and hormone therapy.144 Numerous
large employers have already negotiated contracts with insurance carriers to
enable medically necessary treatment for transsexualism and/or GID to be
covered under their plans.145 More and more carriers are realizing the
effectiveness of the treatment, and coverage is increasingly offered at no
additional premium cost.146
Despite this trend, there are still many instances in which transsexual
individuals are turned away from coverage because the surgery and
hormone therapy are not universally classified as “medically necessary.”147
By contrast, the WPATH statement lists a number of procedures as
medically necessary, including complete hysterectomies, genital
reconstruction, facial hair removal, and certain facial plastic
reconstruction.148 The WPATH Board of Directors has urged insurance
carriers and healthcare providers in the United States not to exclude
transgender or transsexual individuals from coverage and to provide for
prescribed sex reassignment services.149
IV. The European Approach to Transition-Related Medical Care
preferred sex through surgery and hormone treatment.”).
143. See WPATH CLARIFICATION, supra note 133, at 2–3 (defining the medically
necessary sex reassignment procedures).
144. See id. at 1–4 (stating that qualifying procedures as “medically necessary” is
important in terms of access to U.S. insurance coverage and sex reassignment surgeries and
hormone therapies should be classified as such).
145. See id. at 3 (stating that the City and the County of San Francisco, the University
of California, the University of Michigan, and IBM have all negotiated contracts with their
insurance carriers to provide coverage for medically necessary treatment in relation to
transsexualism).
146. See id. (stating that Aetna, Cigna, and other carriers now have protocols
recognizing the validity and effectiveness of treatment).
147. See discussion supra Part II.A (providing United States case law in which sexual
reassignment surgery has been ruled not “medically necessary”).
148. See WPATH CLARIFICATION, supra note 133, at 2 (enumerating various techniques
which may vary from patient to patient including skin flap removal and penile and testicular
prostheses).
149. See id. (emphasizing the need to provide ongoing healthcare, both routine and
specialized, that is readily accessible).
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A number of European countries adhere to the WPATH Standards and
have increased access to critical surgeries and hormone therapies.150 Most
European countries fund some aspects of sexual reassignment surgery,
hormone therapy, or a combination of both.151 Thirteen of the twenty-seven
European Union member states provide funding for psychotherapy, which
extends beyond a mental health evaluation of the patient and continues to
ensure the patient’s mental health throughout the transition period and
afterward.152 Some countries offer psychotherapy only occasionally
because of its high costs.153 Hormone replacement therapy, both before and
after surgery, is provided by at least seventeen countries.154
Many of the countries fund surgical procedures to alter primary and
secondary sex characteristics.155 Primary sex characteristics include
vaginoplasty and phalloplasty.156 Approximately half of the EU countries
fund each of these surgeries.157 For procedures such as phalloplasty, the
quality of the surgery is important in assessing the country’s willingness to
provide funding.158 If the phalloplasty is accomplished through minimal
procedures, a state could be more likely to classify it as cosmetic.159
Conversely, a more extensive surgery might have a better chance at
obtaining funding.160 Funding of primary sex characteristics may therefore
150. See STEPHEN WHITTLE ET AL., TRANSGENDER EUROSTUDY: LEGAL STUDY AND
FOCUS ON THE TRANSGENDER EXPERIENCE OF HEALTH CARE 25 (2008), available at
http://www.ilga-europe.org/home/issues/trans/ie_resources/transgender_eurostudy_legal_
survey_and_focus_on_the_transgender_experience_of_health_care_april_2008 (stating that
many European countries follow the WPATH standards in providing for psychotherapy).
151. See id. (providing general statistics regarding the funding of surgeries and
hormone therapy provided by governments of various European countries).
152. See id. (explaining the comprehensive psychotherapy funded by various European
countries for transitioning patients).
153. See id. (stating that the notable exception to providing psychotherapy is the United
Kingdom because of the high cost of the treatment and the fiscal limitations of the National
Health Service).
154. Id.
155. See id. (citing that up to thirteen countries provide genital reconstruction surgeries
for both men and women).
156. Id.
157. See id. (stating that thirteen countries fund vaginoplasty for transsexual women,
with a similar figure providing phalloplasty for men).
158. See id. at 25–26 (addressing the impossibility of accessing the quality of
treatments provided).
159. See id. (citing vaginoplastics in the Czech Republic as an example of a minimal,
purely cosmetic procedure, that is not funded).
160. See id. (stating that the Czech Republic provides for phalloplasty, which is four to
five times the cost of vaginoplasty, but does not fund vaginoplasties). This may be because
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depend on the surgical method. The secondary sex characteristics include
breast augmentation, bilateral mastectomies, and hysterectomies.161 Over
half of the European Union countries fund bilateral mastectomies and
hysterectomies.162
A. The Changing Legal Landscape
The increase in public funding for sex reassignment procedures is
attributable in part to the changing legal views towards transsexuals in
European courts and law-making bodies.163 Although there were general
successes in combating discrimination against transgender individuals prior
to 2002,164 a wider movement for change began with the European Court of
Human Rights (ECHR) case of Goodwin v. United Kingdom.165 Goodwin
was a post-operative male to female transsexual who alleged that her
employer had dismissed her from work because of her transsexuality.166
The court found that there were violations of Articles 8, 12, and 14 of the
Convention for the Protection of Human Rights and Fundamental Freedoms
(the Convention).167
The ECHR decision upheld protections for
the Czech Republic does not offer the most extensive surgery possible. Id.
161. See id. (stating that six countries fund breast augmentation surgery for transsexual
women).
162. See id. (stating that sixteen countries publicly fund bilateral mastectomies and
fifteen countries fund hysterectomies).
163. See id. at 17–21 (providing an overview of European Union anti-discrimination
legislation including decisions by the European Court of Human Rights and the European
Court of Justice on transgender rights).
164. See id. at 17 (discussing the emergence of protection against discrimination to
transgender people in employment and protection in goods and services).
165. See id. at 18 (stating that Goodwin v. United Kingdom began a broader movement
for transgender legal rights); see also Goodwin v. United Kingdom, App. No 28957/95, Eur.
Ct. H.R. (2002), http://archive.equal-jus.eu/74/1/Christine_Goodwin_v._The_United_
Kingdom_(GC)%2C_no._28957:95.pdf (last visited Oct. 18, 2011) (recognizing the right to
private life and the right to marry for transgendered individuals, and acknowledging that the
United Kingdom national health service and a majority of contracting states, recognize the
condition of gender identity disorder and provide or permit surgery) (on file with the
Washington and Lee Journal of Civil Rights and Social Justice).
166. See Goodwin, App. No. 28957/95, § 15 (stating that although her dismissal was
supposedly connected with her health, applicant argued that it was actually because of her
transsexuality). Applicant also argued that she suffered past discrimination at jobs because
of her transsexuality. Id. In addition, she feared that employers would discriminate against
her without issuance of a new National Insurance number. Id. § 16.
167. See id. § 59 (explaining that Article 8 of the Convention states that “[e]veryone
has the right to respect for his private . . . life”). The court found through a balancing test
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transsexuals for the right to marry, to found a family, and to have their
private lives protected.168
The court in Goodwin also addressed the notion of transsexualism as a
“choice.”169 It stated that most European states acknowledge the existence
of the condition of transsexualism, with the vast majority providing, or at
least permitting, treatment, including irreversible surgeries.170 The court
additionally reasoned that the level of commitment necessary to undergo
gender reassignment surgeries is proof that the decision to undertake
surgery is not an “arbitrary and capricious” decision.171 Because of the
widespread acceptance of transsexualism as a medical diagnosis, the
ongoing debate as to the specific cause is decreasing in relevance since the
most important factor is that transsexuals do not choose the condition.172
The European Court of Human Rights’ acknowledgement of the
importance of gender reassignment surgery paved the way for additional
cases expanding the rights of transsexuals. 173 One such case was L v.
Lithuania174; L was a transitioning female to male.175 He underwent partial
that there were no significant factors of public interest to weigh against the interest of
providing Christine Goodwin with legal recognition of her gender reassignment. Id. § 93;
see also id. § 94 (stating that Article 12 of the Convention provides for the right to marry).
The court concluded that a violation of Article 12 had occurred because of the government’s
denial of applicant’s new insurance number. Id. § 104; see also id. § 105 (stating that
Article 14 of the Convention provides for the rights set forth in the Convention to be secured
without discrimination). The court found that this issue had been examined under Article 8
of the Convention. Id. § 108.
168. See id. § 103 (stating that the court found no justification for barring transsexuals
the right to marry).
169. See id. § 81 (stating that there are no conclusive findings as to the cause of
transsexualism and whether it is psychological or associated with physical differentiation in
the brain).
170. See id. (finding that transsexualism has wide international recognition as a medical
condition with a prescribed treatment).
171. See id. (stating that the numerous painful procedures necessary for gender
reassignment make it unlikely that people undertake the surgery arbitrarily and capriciously).
172. See id. (finding that the ongoing medical and scientific debate as to the exact
causes of transsexualism is of diminishing importance).
173. See L. v. Lithuania, App. No. 27527/03, Eur. Ct. H.R., §§ 59–60 (2008), http://cmi
skp.echr.coe.int/tkp197/view.asp?action=html&documentId=823071&portal=hbkm&source
=externalbydocnumber&table=F69A27FD8FB86142BF01C1166DEA398649 (last visited
Oct. 18, 2011) (finding that Lithuania violated the Convention for the Protection of Human
Rights and Fundamental Freedoms by not allowing procedures for gender reassignment
surgery) (on file with the Washington and Lee Journal of Civil Rights and Social Justice).
174. See id. (finding a violation of the Convention for the Protection of Human Rights
and Fundamental Freedoms by the Lithuanian government).
175. See id. § 7 (stating that the applicant knew from an early age that he was aware his
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gender reassignment surgery by having his breasts removed and agreed
with his doctors that further surgeries were appropriate.176 In order to
receive the further treatment he needed in Lithuania, L was waiting on the
passage of a Gender-Reassignment Bill.177 The government delayed
passing the bill, which meant that the surgery could not be conducted in
Lithuania.178 Without the additional surgery, L remained female under
domestic law.179 The court found that the government had waited too long
to implement the laws that would allow for the completion of gender
reassignment surgery.180 By not allowing this type of surgery in the
country, the Lithuanian government violated Article 8 of the Convention
for the Protection of Human Rights and Fundamental Freedoms.181 With a
majority of European Union states offering gender reassignment surgery, L
v. Lithuania gave strong support to transsexuals seeking all aspects of the
transition process.
There have also been significant gains relating directly to insurance
coverage for transition-related care.
An issue paper by Thomas
Hammerberg, the Council of Europe Commissioner for Human Rights,
examines the current ability of transgender individuals to access transitionrelated services, if they choose to transition.182 The case law of the ECHR
requires states to at least provide for the possibility of surgeries that will
eventually lead to full gender reassignment, as was the case in L v.
Lithuania.183 Additionally, the Commissioner notes that case law also
mental state was male).
176. See id. § 19 (stating that L underwent breast removal from May 3 to May 9, 2000).
177. See id. §§ 25–30 (describing the Civil Code adopted in 2001, which provided that
an unmarried adult had the right to gender reassignment surgery, and noting that the Gender
Reassignment Bill, which was to be added to the Civil Code, was omitted from the
Parliament’s agenda).
178. See id. § 30 (stating that the government dropped the Gender Reassignment Bill
from the Parliament’s agenda).
179. See id. § 39 (detailing L’s argument that the removal of the Gender Reassignment
Bill left him without the ability to finish his transition).
180. See id. § 59 (finding that budgetary constraints do not justify four years of inaction
on legislation).
181. See id. § 60 (concluding the government violated Article 8).
182. See Thomas Hammerberg, Human Rights and Gender Identity, OFFICE OF COMM’R
FOR HUMAN RIGHTS, 7–8 (July 29, 2009), https://wcd.coe.int/com.instranet.InstraServlet?
Index=no&command=com.instranet.CmdBlobGet&InstranetImage=1824655&SecMode=1
&DocId=1433126&Usage=2 (stating that the paper addressed the human rights concerns
regarding transgender person).
183. See id. at 26 (“The European Court of Human Rights has established as a positive
duty that states provide for the possibility of undergoing surgery leading to full gender-
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states that insurance plans in the European Union should cover “medically
necessary” treatment in general, which includes gender reassignment
surgery.184 The Commissioner goes further to say that all Council of
Europe member states should apply that standard to insurance plans in their
respective countries.185
B. Coverage of Transition-Related Procedures in Specific Countries
While standards for the transition-related care have clearly begun to
emerge in Europe, there are still inadequacies in many European Union
countries. Ultimately 80% of transgender people in the EU were refused
state funding for hormone treatment, and 86% of transgender people are
refused state funding for surgical procedures.186 Because of the persistent
difficulty in obtaining state funds, 50% of transgender individuals in the EU
must individually pay for their procedures.187 These statistics are surprising
given the recent successes for the European transgender community.188
One of the biggest reasons for the high rate of refusal for funding is the
European Union’s lack of enforcement.189 It is therefore necessary to
examine some important European countries in detail, in order to see which
surgeries they most often fund, the processes for state funding, and why
countries might be failing at the implementation phase.
1. The United Kingdom

reassignment.”).
184. See id. (stating that European Court of Human Rights case law calls for coverage
under insurance plans).
185. See id. (stating that the standards should be adopted by all Council of Europe
states).
186. See WHITTLE, supra note 150, at 54 (finding that more respondents who
transitioned less than five years ago had been refused funding for hormones than those who
transitioned more than ten years ago).
187. See id. at 56–57 (providing the percentage of respondents who were refused
treatment and paid themselves).
188. See id. at 54 (“This is a worrying finding as the assumption would be that access to
funding for treatment would be improving.”).
189. See id. at 68 (“One of the most frustrating aspects of the EU for trans people has
been its failure to ensure that Member States are meeting their obligations under the
directives, regulations, policies and case law.”).
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The United Kingdom has established one of the most universal
healthcare systems in the world. All people “ordinarily resident” in the
United Kingdom are entitled to health care.190 The National Health
Services (NHS) of England, Scotland, Wales, and Northern Ireland
accounts for 86% of total health expenditure and is funded through general
taxation.191 In England, the Department of Health holds the management
responsibility, while decisions about service delivery and local priority lie
with the Strategic Health Authorities and the Primary Care Trusts.192
In the United Kingdom, the treatment referral pathway for gender
reassignment surgery is often similar to the one utilized in the United States
and generally follows the WPATH standards.193 The Worcestershire
Commissioning Policy and Referral Guidelines for Gender Dysphoria
Services gives an example of this pathway.194 A physician must first
diagnose the patient with Gender Identity Disorder.195 Leading up to the
commencement of hormone therapy, the patient must perform the real life
test (RLT), which includes a minimum of two years living as the opposite
gender to that assigned at birth.196 After three months of the RLT, the
patient begins the initial phases of hormone therapy.197 Surgery is allowed
only if the patient meets strict qualifications, including performing the RLT,
obtaining ongoing hormone therapy, and changing his or her name
legally.198 There are problematic qualifications in parts of the United
190. See Sean Boyle, The UK Health Care System, THE COMMONWEALTH FUND (2008),
http://www.commonwealthfund.org/usr_doc/UK_Country_Profile_2008.pdf?section=4061
(last visited Oct. 18, 2011) (“Coverage is universal.”) (on file with the Washington and Lee
Journal of Civil Rights and Social Justice).
191. See id. (stating that the NHS is mainly funded by general taxation, as well as by
national insurance contributions and user charges).
192. See WHITTLE, supra note 150, at 33 (discussing the National Health System in the
United Kingdom).
193. See supra Part III.B (discussing the WPATH Standards of Care).
194. See WORCESTERSHIRE PRIMARY CARE TRUST, COMMISSIONING POLICY AND
REFERRAL GUIDELINES FOR GENDER DYSPHORIA SERVICES AND GENDER REASSIGNMENT
SURGERY IN ADULTS 2 (July 2008), available at http://www.worcestershire.
nhs.uk/search.aspx?q=%22GENDER+DYSPHORIA+SERVICES%22&type=docs
[hereinafter COMMISSIONING POLICY] (stating that the guidelines describe the criteria for
referral to gender identity services and for gender reassignment surgery).
195. See id. at 4 (stating that patients must have an initial diagnosis of transsexualism or
GID by a local consultant psychiatrist).
196. See id. at 5 (stating that periods of returning to their original gender should be
excluded from the two year RLT).
197. See id. (including the criteria that patients demonstrate knowledge of what
hormones can and cannot do medically).
198. See id. (requiring that the patient change his or her name to one “appropriate to the
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Kingdom. One such qualification is the requirement that the patient
maintain employment or education in the desired gender role for a
minimum of one year.199 This is often difficult due to discrimination in
areas of employment and education.200 Additionally, patients may be
forced to wait up to three years for surgery due to the current demand for
the procedures.201
Despite some shortcomings in the specific referral process, the
United Kingdom provides funding for most aspects of transition-related
care under the NHS.202 Among the funded procedures are hormone
replacement
therapy,
bilateral
mastectomies,
hysterectomies,
vaginoplasties, and phalloplasties.203
Assuming that full gender
reassignment constitutes surgery to augment the genitals and hormone
replacement therapy, funding for these procedures is a success for
transgender individuals living in the United Kingdom because it
provides for the minimum number of procedures to achieve full gender
reassignment.204 Some individuals may feel that other procedures are
crucial to his or her complete transition. Psychotherapy, often seen as a
crucial part of the gender reassignment process, is not available from the
NHS because of the therapy’s high cost and the fiscal limits of the
NHS.205 In addition, procedures such as permanent hair removal and
breast augmentation surgeries are not considered crucial aspects to the
gender reassignment process and are not covered by the NHS.206 There
are therefore notable shortcomings since numerous procedures are not
covered under the national health plan. Transsexual individuals desiring
to undergo those procedures may find aid, however, from the strong
transgendered self”).
199. See id. (“Patients should have found employment, or been in education or training,
in their desired gender role for a minimum period of one year, including employment in the
voluntary sector.”).
200. See discussion supra note 166 (discussing Goodwin v. United Kingdom and the
difficulties Christine Goodwin faced in terms of employment).
201. See HEATH, supra note 30, at 93 (stating that many clients seek private surgical
arrangements because the National Health Service waiting time is three years).
202. See WHITTLE, supra note 150, at 25 (detailing the procedures publically funded by
the United Kingdom).
203. Id.
204. Id.
205. See id. (stating that the fiscal limitations of the NHS prevent some funding for
psychotherapy).
206. See COMMISSIONING POLICY, supra note 194, at 6 (stating that “breast presence or
size is not a defining characteristic of sex or gender”).
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suggestion that insurance plans should cover all “medically necessary”
procedures.207 While breast augmentation and hair removal are still
largely seen as cosmetic, psychotherapy may have a better chance at
being classified as “medically necessary” because it is one of the
prerequisites for surgery.
Other shortcomings exist for transsexual individuals after surgery.
For many years, the government refused to change identification
documents to match the new sex.208 In 2002, the ECHR issued a
statement to the British government telling it to recognize new gender
statuses on government documents.209 While there have been some
successes in the United Kingdom with legislation such as the Gender
Recognition Act of 2004, there are still areas of protection that need
improvement.210 One example of necessary improvements is in the area
of pension rights. The Council of Europe Commissioner for Human
Rights has found that transgender women have been denied the same
pension rights received by other women in the United Kingdom.211 Even
with the need for improvements in areas after surgery, the United
Kingdom is still a prime example of how European countries are
expanding rights for transgender individuals and recognizing most
aspects of gender reassignment surgery as “medically necessary.”
2. Germany and Sweden
Unlike the United Kingdom, Germany and Sweden provide funding
for every aspect of the gender reassignment process.212 In Germany, care is
207. See discussion supra note 182 and accompanying text (discussing Thomas
Hammerberg’s call for all European Union members to cover SRS under insurance plans).
208. See GREEN, supra note 1, at 92 (stating that prior to 2002 transsexuals faced
difficulties in obtaining employment, pensions, and marriage licenses).
209. See id. (stating that the order resulted from a thirty-year battle involving numerous
petitions from British citizens).
210. See Gender Recognition Act, 2004, c. 7, § 9 (U.K.) (stating that when a full gender
recognition certificate is issued, the person’s gender becomes the acquired gender).
211. See Discrimination Against Transgender Persons Must No Longer be Tolerated,
STOP TRANSPHOBIA (Jan. 11, 2009) http://stoptransphobia.wordpress.com/2009/01/11/%E2
%80%9Cdiscrimination-against-transgender-persons-must-no-longer-be-tolerated%
E2%80%9D/ (last visited Nov. 3, 2011) (providing an excerpt from the Commissioner for
Human Rights detailing the failures of the United Kingdom government) (on file with the
Washington and Lee Journal of Civil Rights and Social Justice).
212. See WHITTLE, supra note 150, at 22 (detailing the procedures publically funded by
Germany and Sweden).
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financed by a combination of statutory health insurance, general taxation,
private health insurance, and some user co-payments.213 Compulsory
contributions, split between employers and employees, are put into one of a
large number of sickness funds.214 The type of sickness fund determines
how much a person must contribute and the type of healthcare services
available.215 Sweden has a similar universal healthcare structure. Services
are covered based on three main principles: equal access, care based on
need, and cost effectiveness.216 Approximately 70% of healthcare services
in Sweden are funded through local government taxes.217 In 2007, only 3%
of the Swedish population was covered by private insurance.218
German and Swedish transsexuals have the possibility to obtain statesponsored funding of all transition-related treatments.219 Providing public
funding for hair removal is a unique and important success.220 Hair
removal is similar in cost to full genital surgery and is often considered
essential in order to live successfully as a woman.221 In addition to hair
removal procedures, Germany provides breast augmentation surgery for
transsexual women.222 Both Germany and Sweden provide funding for
psychotherapy,
vaginoplasty,
mastectomy,
phalloplasty,
and
metoidioplasty.223
213. See REINHARD BUSSE, THE COMMONWEALTH FUND, THE GERMAN HEALTH CARE
SYSTEM 2–3, http://www.allhealth.org/briefingmaterials/CountryProfiles-FINAL-1163.pdf
(last visited Nov. 3, 2011) (stating that the publicly funded scheme is operated by over 200
competing health insurance funds) (on file with the Washington and Lee Journal of Civil
Rights and Social Justice).
214. See WHITTLE, supra note 150, at 31–32 (“Currently, the healthcare system is
funded by compulsory contributions that are split between employers and employees and are
put into one of a large number of sickness funds.”).
215. See id. (stating that the 252 sickness funds insure approximately 90% of the
population).
216. See Sweden’s HealthCare System, SWEDISH HEALTHCARE ACADEMY,
http://www.swedishhealthcare.se/sida1.html (last visited Nov. 3, 2011) (stating that those
included are not actually enumerated) (on file with the Washington and Lee Journal of Civil
Rights and Social Justice).
217. See id. (stating that most of the public financing comes from county council taxes).
218. See id. (suggesting that private insurance is on the rise).
219. See WHITTLE, supra note 150, at 22 (providing a chart of all the procedures
Germany and Sweden publicly fund).
220. See id. at 25 (stating that only Germany and Sweden publicly fund hair removal).
221. See id. (stating that the cost of hair removal greatly exceeds the cost of breast
augmentation and that it is similar to the cost of full genital surgery).
222. See id. (including Germany as one of six countries that proved public funds for
breast augmentation).
223. Id.
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While both countries allow for the possibility of government funding
for all procedures, the systems have some limitations and drawbacks. For
example, both countries fund the surgeries, but still require sterilization in
order to have birth records changed after surgery.224 In the United
Kingdom, a person can easily change his or her name, but Germany and
Sweden require all aspects of surgery and hormone treatment in addition to
permanent sterility in order for a name change to be granted.225 There is,
however, a trend towards greater protection for transitioned individuals.
Swedish Prime Minister Fredrik Reinfeldt and the National Board of Health
and Welfare are making efforts to remove the law in Sweden that requires
permanent sterility.226 The transsexual community in Germany is hopeful
that the new government will reform the “Transsexual Law” and deal with
some of these issues within the next legislative period.227
Finally, both systems are constrained by monetary issues. Sweden’s
system is based on need and cost effectiveness.228 Even if all of the
procedures are determined to be necessary to an individual patient, cost
effectiveness could play a role and eliminate more traditionally “cosmetic”
surgeries, such as breast augmentation and hair removal.229 The same is
true for Germany, where long-term affordability of healthcare reform
remains a strong concern.230 If costs are too high, it may mean that national

224. See WHITTLE, supra note 150, at 26 (stating that France, Germany, Lithuania, and
Sweden can sometimes require permanent sterility).
225. See id. (stating that the United Kingdom has no legal obstruction to changing a
person’s name to something that is more appropriate to their new gender, while Germany
and Sweden require medical intervention up to and including treatment to render permanent
sterility).
226. See Sex Change Sterilization “A Dark Chapter”: Reinfeldt, THE LOCAL (Jul. 13,
2010), http://www.thelocal.se/28114/20100731/ (last visited Nov. 3, 2011) (stating that
leaders of Sweden’s seven political parties have expressed support to amend legislation that
forces compulsory sterilization in order to get a divorce after a sex change) (on file with the
Washington and Lee Journal of Civil Rights and Social Justice).
227. See C. Balzer & A. Suess, TvT Research Project Country Results: Germany—
Elaborated Version, TRANS RESPECT VERSUS TRANSPHOBIA WORLDWIDE (Jan. 2010)
http://www.transrespect-transphobia.org/en_US/countries/germany-1/germany-2.htm (last
visited Nov. 3, 2011) (providing a list of initiatives regarding the recognition of transgender
rights in the national constitution) (on file with the Washington and Lee Journal of Civil
Rights and Social Justice).
228. See discussion supra at note 216 and accompanying text (describing Sweden’s
healthcare system).
229. See id. (describing Sweden’s healthcare system).
230. See WHITTLE, supra note 150, at 32 (stating that long-term affordability remains
an important concern for Germany’s healthcare system).
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health insurances will not cover breast augmentation or hair removal.231
What is important, however, is that transgender individuals in Germany and
Sweden have some options for funding under a national insurance plan, a
private insurance plan, or a combination of the two. These choices are in
stark contrast to the situation in the United States, where insurance
providers can exclude coverage as they see fit.232
3. Italy and Spain
Several European countries, such as Italy and Spain, are severely
lacking in provisions for transgender needs, but even these countries have
shown some positive trends. Italy provides for gender reassignment
surgery free of charge in hospitals, but the procedures are subject to the
authorization of courts.233 Surgical procedures to alter both primary and
secondary sex characteristics are funded by the Italian government.234 Italy
applies its own set of standards for determining eligibility and providing
reassignment procedures.235 The Italian standards state that SRS can be
carried out after obtaining a court order.236 In order to get a court order,
individuals must meet certain qualifications, including the criteria for
reassignment established in DSM-IV and ICD-10.237 Hormone replacement

231. See Balzer & Suess, supra note 227 (stating that health insurance in Germany does
not often cover hair removal or breast augmentation).
232. See supra Part II.B (discussing how insurance companies can exclude coverage for
various medical procedures).
233. See Submission to the United Nations Human Rights Council for its Universal
Periodic Review of Italy, Italy: The Status of Lesbian, Gay, Bisexual and Transgender
Rights 5 (Seventh Session) http://lib.ohchr.org/HRBodies/UPR/Documents/Session7/IT/J1
_UPR_ITA_S07_2010_JointSubmission1.pdf (last visited Nov. 3, 2011) (stating that gender
reassignment surgery is subject to the authorization of courts) (on file with the Washington
and Lee Journal of Civil Rights and Social Justice).
234. See WHITTLE, supra note 150, at 22 (providing a chart of the procedures Italy
publicly funds, including vaginoplasties, hysterectomies, and phalloplasties).
235. See Anna R. Ravenna, Italian Standards of Care for Sex Reassignment in Gender
Identity Disorder, 2 INT’L J. OF TRANSGENDERISM 4 (1998), available at
http://www.iiav.nl/ezines/web/IJT/97-03/numbers/symposion/ijtc0602.htm#STANDARDS
%20OF%20CARE%20FOR%20SEX%20REASSIGNMENT%20IN%20GENDER%20IDE
NTITY%20DISORDER%20(DSM%20IV%20302.85) (stating that the standards are to be
minimal requirement recommendations only).
236. See id. at Procedure Criteria B5 (stating that a court order and a common
agreement of the operators must be obtained in order to undergo surgery).
237. See id. (explaining the requirements for obtaining a court order).
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therapy is also not provided by the Italian government even though it is
required before a court will allow surgery.238
Spain is another example of a European country that does not offer
much protection for its transgender community, especially funding for
gender reassignment surgery.239 At the time of the Transgender Eurostudy,
Spain provided public funding only for hormone therapy and
psychotherapy.240 Occasionally the government has provided funding for
vaginoplasties, but it does not provide funding for primary and secondary
surgical procedures, hair removal, or breast augmentation.241
There have been recent movements in Spain to include gender
reassignment procedures in the public health services.242 The political
parties Bloque Nacionalista Gallego and Esquerra Republicana Catalunya
have supported proposals that would include the gender reassignment
process in the national Public Health System.243 There are several
autonomous communities within Spain that have included gender
reassignment procedures as covered services, including Aragon, Asturias,
Basque Country, Canaries, Catalonia, Community of Madrid, Community
of Valencia, and Extremadura.244 While there are no standard protocols for
all of these communities, the process largely adheres to the WPATH
Standards of Care.245 If a surgery is not offered in an area, patients are
referred to units that provide them.246 In some cases, if a person is referred

238. See WHITTLE, supra note 150, at 22 (stating that Italy does not provide public
funding for hormone therapy).
239. See id. (indicating that Spain provides public funds for psychotherapy and
hormone therapy).
240. Id.
241. See id. (stating that Spain has occasionally provided funding for vaginoplasties).
242. Id.
243. See TVT Research Project Country Results: Spain—Elaborated Version, TRANS
RESPECT VERSUS TRANSPHOBIA WORLDWIDE, (May 2010) http://www.transrespecttransphobia.org/en_US/countries/spain-1/spain-2.htm (last visited Nov. 3, 2011) (stating that
the political parties have pressed for coverage of gender reassignment process on the
national level) (on file with the Washington and Lee Journal of Civil Rights and Social
Justice).
244. See id. (providing a list of autonomous communities that have opted to cover the
gender reassignment process).
245. See id. (stating that “Gender Identity Disorders Units” are set up according to the
WPATH Standards of Care).
246. See id. (explaining that patients are referred to units if the unit they are currently in
does not perform the needed surgery).
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to a different area, the public health system will pay for the referral costs,
but that payment is not a guarantee.247
Italy and Spain are therefore two examples of European countries that
provide the least in terms of funding for gender reassignment procedures.248
Despite those failures, both countries show evidence of change towards
greater protection for transgender individuals. Italy provides funding for
surgeries subject to court approval.249 Transgender individuals have access
to surgeries, but improvements in financing hormone therapy and long-term
care are necessary. Spain, on the other hand, offers little national funding
for gender reassignment, but specific communities have begun to cover
transition-related procedures.250
The evidence of political parties
attempting to include gender reassignment procedures under the national
health scheme provides another example of the changing attitude similar to
other European countries.
4. Summary of the Country-by-Country Analysis
While current statistics show that many transitioning individuals in
Europe are denied funding for their treatments, there are a few explanations
and important lessons from the experiences in the United Kingdom,
Germany, Sweden, Italy, and Spain.251 First, monetary constraints are an
important factor in providing adequate care.252 Transsexuals in the United
Kingdom face long waiting lists because of a lack of resources, while those
in Germany and Sweden are denied funding for certain procedures in order
to save costs.253 Second, there is a problem with enforcement of health
standards, especially from the European Union.254 There is an immense
247. See id. (stating that a national fund called Fondo de Cohesión Sanitaria provides
funding for referrals).
248. See WHITTLE, supra note 150, at 22 (indicating the publicly funded procedures
provided in Spain and Italy).
249. See discussion supra note 233 and accompanying text (explaining the need for
Court approval).
250. See discussion supra note 244 and accompanying text (indicating communities
willing to cover transgender surgeries).
251. See supra Part IV.B (providing the statistics of transsexuals denied funding in
Europe).
252. See supra Part IV.B.2 (describing the monetary constraints of Germany and
Sweden).
253. See supra Part IV.B.1 (describing the waiting list of the United Kingdom).
254. See supra Part IV.B (discussing the lack of enforcement).

THE NEED FOR CHANGE

385

difficulty in preventing all types of discrimination, including by individual
insurance agencies and medical facilities.
The country-by-country analysis demonstrates that a majority of
European countries are recognizing the need for some form of coverage of
Gender Reassignment Surgery. Even in Italy and Spain, countries that fund
very few procedures, there are large movements pushing for reform.255
Additionally, examination of the European countries provides a strong
argument in favor of classifying all of the procedures associated with
gender reassignment as “medically necessary.”256 The lessons of the
European community should be used as a framework for providing
transsexuals in the United States with adequate care.
V. Conclusion: Applying Lessons from the International Community to the
United States
There is already significant evidence that the American medical
community is amenable to the standards established by the WPATH and in
Europe.257 First, the American Medical Association (AMA) passed a
resolution on June 16, 2008, supporting public and private health insurance
coverage for treatment of gender identity disorder.258 The resolution states
that an established body of medical research demonstrates the effectiveness
and medical necessity of mental health care, hormone therapy, and SRS.259
Further, the categorical exclusion of surgical treatments for GID in health
insurance plans represents discrimination based solely on the patient’s
gender identity.260
A second example that the United States is amenable to these
standards came with the 2010 decision by the United States Tax Court in
255. See supra Part IV.B.3 (describing the current political movements in Italy and
Spain).
256. See supra Part IV (providing an explanation of the European approach to
transgender reassignment procedures).
257. See AM. MED. ASS’N, REMOVING FINANCIAL BARRIERS TO CARE FOR TRANSGENDER
PATIENTS, RES. 122 (June 16, 2008), available at http://www.gires.org.uk/assets/MedproAssets/AMA122.pdf (supporting public and private health insurance coverage for treatment
of GID).
258. See id. (recognizing WPATH has improved understanding and treatment for GID).
259. See id. (stating that health experts, including WPATH have rejected the myth that
transition-related procedures are “cosmetic” or “experimental”).
260. See id. (stating that delaying treatment can also aggravate and cause serious health
problems).

386

18 WASH. & LEE J.C.R. & SOC. JUST. 351 (2012)

O’Donnabhain v. Commissioner of Internal Revenue.261 The court ruled
that sex reassignment surgeries qualify as deductible medical expenses
under IRS Code § 213.262 This court ruling indicates that hormone therapy
and transition-related surgeries are not considered “cosmetic.”263 The
opinion further recognizes that breast augmentation is not cosmetic in
certain circumstances.264
Viewing the recent Tax Court decision, the AMA resolution, the
differing standards among the states, and the statements by WPATH urging
the United States to reform in conjunction, it is clear that uniform change
needs to occur in the United States. While there are still a significant
number of European transgender individuals who must pay for their own
procedures, the recognition that gender reassignment procedures are
medically necessary is apparent. Some argue that classification of GID as a
mental disorder creates further issues,265 but under current international
standards, diagnosis with GID is crucial to obtaining care.266 Once
diagnosed with GID, Americans should have adequate access to the
necessary treatments.
In order for the United States to meet the standards of care most
European countries ascribe to, there can be no categorical exclusion of
gender reassignment procedures under insurance plans. Resolving the
exclusion problem under state Medicaid statutes ultimately depends on
whether the procedures pursued by transgendered individuals qualify as
“medically necessary.” The international community studied in this
discussion presents an increasingly clear consensus that transition-related
procedures are in fact medically necessary for those individuals diagnosed
with GID.267 The predominant standards of care are those developed by
WPATH which explicitly states that all transition-related processes are

261. See O’Donnabhain v. Comm’r of Internal Revenue, 134 T.C. No. 4, at *25 (2010)
(finding that petitioner suffered from GID and finding that hormone therapy and SRS were
effective treatments).
262. See id. at *26 (stating that petitioner showed her surgeries were not cosmetic and
that she should be allowed a deduction for them as medical care).
263. Id.
264. See id. at *23 (stating that breast augmentation surgery can sometimes be required
under the Harry Benjamin Standards of Care).
265. See discussion supra note 28 and accompanying text (indicating GID can lead to
depression and suicide).
266. See WHITTLE, supra note 150, at 71 (stating that a medical diagnosis is necessary
to ensure treatment).
267. See supra Part IV (explaining the various procedures funded by European nations).
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necessary for a transsexual to live a complete and full life.268 Although
some European countries do not provide funding for all aspects of
transition-related care, most acknowledge that the procedures are medically
necessary.269 In countries not already acknowledging the necessities of
these procedures, such as Italy and Spain, movements have begun to take
shape encouraging them to follow the WPATH standards.270
Application of these international lessons can occur at either the
federal or the state level. Including the WPATH standards in federal
legislation would be ideal to provide uniform coverage. This could be done
through the national Medicaid statute or in a national health care bill such
as the Patient Protection and Affordable Care Act. Through this method,
the WPATH Standards of Care could be enumerated and the specific
procedures could be classified as “medically necessary.” Advocates for the
transgender community such as Pooja Gehi and Gabriel Arkles have
pointed out the difficulties of such a solution.271 The topic is one of intense
debate and disagreement. Additionally, the current economic conditions in
the United States, the national debate over health care, and the unresolved
nature of the medical necessity of transition-related procedures in the
United States all produce difficulties for creating national legislation on the
issue. Instead, Gehi and Arkles have suggested that the focus of change
should be on the state level first.272
States should explicitly declare that transition-related procedures are
medically necessary for Medicaid purposes and adopt the WPATH
standards. The main challenge is the disagreement among the medical
community in the United States.273 One way to encourage states to adopt
uniform legislation is through a body such as the Uniform Law
Commission.274 The commission could take the information learned from
268. See supra Part III.B (describing the WPATH Standard of Care).
269. See supra Part IV (describing the current position of Europe in regards to
transition-related care).
270. See supra Part IV.B.3 (discussing Italy and Spain).
271. See Dean Spade, Interview, Medicaid Policy & Gender-Confirming Healthcare for
Trans People: An Interview with Advocates, 8 SEATTLE J. FOR SOC. JUST. 497, 509 (2010)
(stating that now is not the time to raise concerns on a federal level).
272. See id. (suggesting an approach on the state or local levels).
273. See supra Part II (discussing the different approaches to transition-related care in
the United States).
274. See UNIFORM LAW COMMISSION, http://www.nccusl.org/Default.aspx (last visited
Nov. 3, 2011) (stating that the Uniform Law Commission strives to provide uniform
legislation to states) (on file with the Washington and Lee Journal of Civil Rights and Social
Justice).
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the international community and use it to create legislation that is uniform
across states. While individual states will have to be convinced to adopt the
legislation, the Uniform Law Commission is a convenient way to present
the current information to them. States need uniformity under their
Medicaid statutes in order to prevent court decisions such as Casillas and
Smith.275 Standardization would also help to provide more support to
transsexual individuals through private health insurance. Because private
insurance operates under contract law, the individual purchasing the
insurance must ensure that there is adequate coverage for his or her needs.
When the contract is ambiguous, as in Davidson, having uniform medical
standards would provide aid to transgender individuals arguing that
transition-related procedures are not cosmetic.276
The situation is dire and calls for action. The lack of uniform medical
standards for transition-related services leaves many transsexuals without
necessary procedures and causes some to turn to such extremes as
prostitution or traveling to countries with less restrictive medical
standards.277 European countries are already seeing this trend and
recognizing the need to provide for the medical procedures. The United
States should follow the international example. While it may be difficult to
promote federal legislation at the moment, states should adopt the
international standards and apply them to state Medicaid programs.
Hopefully, once the medical community in the United States has recognized
the necessity of these procedures, the national government will be able to
follow suit and provide even further protection. These measures will help
to fulfill the fact that transsexualism is not about surgery, but about life.

275. See supra Part II.A (discussing the differing approaches for upholding denials of
reimbursements for transition-related procedures).
276. See supra Part II.B (discussing Davidson v. Aetna Life & Cas. Ins. Co.).
277. See supra Part II.C (discussing the serious consequences of denying
reimbursement for transition-related services).

